FDA taps critic of COVID policies, drug industry to lead vaccines division
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation and Research (CBER), who resigned in March after clashing with Health…
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
.png?Expires=1838763821&Key-Pair-Id=K2ZIVPTIP2VGHC&Signature=IO0~CT3pU-TcxGc~yoZSmoQx23MZVuK-~4jSii~NKEblRmyO3el7NXPu~Rh1o23voASg7hlcHLw4kvQuDK1jssEhcjoNBBvEpZ~GGOAU6yosBhpHpeF179F~h7i6VxmsBNh9gtTutkoqY73O2YCFey~IAqSzKbBqETP1kP9cAg1916Z1YkJJs-5MliMrkZ5d7-mWGLbpHp2wGj2VlMph8XzYlL4~y1O7fB~JdIS~Rs4RMRs2x0WT1qUIpHAsf3GdwtOyAmKFSpIg8xCyNGZZ5h~13nXlmpd7uPvW8tBfttpG9pFTqcway-uch5WyfHOEfi7UlJCOWrr6fCYY5PMgSg__)
